Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experiences and intentions of Ugandan household tuberculosis contacts receiving test results via text message: an exploratory study.
Ggita JM, Katahoire A, Meyer AJ, Nansubuga E, Nalugwa T, Turimumahoro P, Ochom E, Ayakaka I, Haberer JE, Katamba A, Armstrong-Hough M, Davis JL. Ggita JM, et al. Among authors: katahoire a. BMC Public Health. 2020 Mar 12;20(1):310. doi: 10.1186/s12889-020-8427-0. BMC Public Health. 2020. PMID: 32164612 Free PMC article. Clinical Trial.
Prevalence, associated factors and perspectives of HIV testing among men in Uganda.
Nangendo J, Katahoire AR, Armstrong-Hough M, Kabami J, Obeng-Amoako GO, Muwema M, Semitala FC, Karamagi CA, Wanyenze RK, Kamya MR, Kalyango JN. Nangendo J, et al. Among authors: katahoire ar. PLoS One. 2020 Aug 7;15(8):e0237402. doi: 10.1371/journal.pone.0237402. eCollection 2020. PLoS One. 2020. PMID: 32764820 Free PMC article.
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.
Kadota JL, Musinguzi A, Nabunje J, Welishe F, Ssemata JL, Bishop O, Berger CA, Patel D, Sammann A, Katahoire A, Nahid P, Belknap R, Phillips PPJ, Namusobya J, Kamya M, Handley MA, Kiwanuka N, Katamba A, Dowdy D, Semitala FC, Cattamanchi A. Kadota JL, et al. Among authors: katahoire a. Implement Sci. 2020 Aug 12;15(1):65. doi: 10.1186/s13012-020-01025-8. Implement Sci. 2020. PMID: 32787925 Free PMC article.
Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.
Semitala FC, Musinguzi A, Ssemata J, Welishe F, Nabunje J, Kadota JL, Berger CA, Katamba A, Kiwanuka N, Kamya MR, Dowdy D, Cattamanchi A, Katahoire AR. Semitala FC, et al. Among authors: katahoire ar. Implement Sci Commun. 2021 Jun 30;2(1):71. doi: 10.1186/s43058-021-00173-2. Implement Sci Commun. 2021. PMID: 34193311 Free PMC article.
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda.
Twimukye A, Laker M, Odongpiny EAL, Ajok F, Onen H, Kalule I, Kajubi P, Seden K, Owarwo N, Kiragga A, Armstrong-Hough M, Katahoire A, Mujugira A, Lamorde M, Castelnuovo B. Twimukye A, et al. Among authors: katahoire a. BMC Infect Dis. 2021 Nov 13;21(1):1154. doi: 10.1186/s12879-021-06851-9. BMC Infect Dis. 2021. PMID: 34774018 Free PMC article.
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
Semitala FC, Kadota JL, Musinguzi A, Nabunje J, Welishe F, Nakitende A, Akello L, Bishop O, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PPJ, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A. Semitala FC, et al. Among authors: katahoire a. PLoS Med. 2021 Dec 16;18(12):e1003875. doi: 10.1371/journal.pmed.1003875. eCollection 2021 Dec. PLoS Med. 2021. PMID: 34914696 Free PMC article. Clinical Trial.
76 results